Previous studies have employed liposomal nanotechnology to deliver Ginkgo flavone glycosides, demonstrating that this approach can activate SIRT1 and alleviate the pathological processes of diabetic cardiomyopathy by modulating oxidative stress and inflammatory responses [59]. The gene discussed is SIRT1; the disease is diabetic cardiomyopathy.